#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bladder cancer Complex regional pain syndrome Primary adrenal insufficiency Nephrotic syndrome Epstein-Barr virus infection Arterial disorder Immunodeficiency common variable Small cell lung cancer Pyruvate kinase deficiency anaemia Thrombocytosis Dilated cardiomyopathy Glomerulonephritis rapidly progressive Haemophilia B without inhibitors Hepatic angiosarcoma Macular telangiectasia More trials…

    Learn about Rare Diseases

    Glomerulonephritis rapidly progressive – Basic Information Rhabdomyosarcoma recurrent – Life with Disease Lymphangioma – Treatment Indolent systemic mastocytosis Carcinoid syndrome – Trials in Disease Fabry’s disease – Trials in Disease Hereditary hypophosphataemic rickets – Treatment Pleomorphic leiomyosarcoma – Diagnostics Progressive supranuclear palsy Retinoblastoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Latanoprost Sodium Citrate Guanabenz Acetate ULEFNERSEN FIBRIN Losartan Potassium Clomifene Citrate Domvanalimab Omp65 Ngi226 Darolutamide Lumasiran Ramipril Pimozide Sotalol Hydrochloride Ranibizumab Forimtamig Ciprofloxacin Hydrochloride Gsk4004280 Calcium Folinate More therapies…

    Learn about Your Condition

    Eclampsia Tetanus Dyspepsia Septic shock Anal fistula Cachexia Senile dementia Asplenia Breast cancer stage I Diabetic retinopathy Dry mouth Urticaria Bone marrow disorder Malformation venous Amnestic disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Asthma

  • A Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma

    Recruiting

    2 1
    Investigated Drugs:
    • LY3537031
    France Germany The Netherlands Poland

  • A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

    Recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Austria Belgium Germany Italy Poland Romania +2

  • Tezepelumab Effects on TSLP Protein Induction in Adults with Severe Asthma, With and Without Chronic Rhinosinusitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tezepelumab
    Denmark

  • Efficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations

    Recruiting

    3 1 1
    Investigated Drugs:
    • Depemokimab
    Belgium Bulgaria Czechia France Germany Ireland +3

  • Efficacy and Safety of Inhaled Glycopyrronium Bromide Added to Budesonide and Formoterol Fumarate in Children 4‑12 Years with Asthma (Placebo‑Controlled)

    Recruiting

    2 1
    Investigated Drugs:
    • Formoterol Fumarate
    • Glycopyrronium Bromide
    • Budesonide
    Czechia Hungary Poland

  • Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

    Recruiting

    3 1 1
    Investigated Drugs:
    • Indacaterol Acetate
    • Salmeterol
    • Fluticasone Propionate
    France Germany Hungary Poland Romania Slovakia +1
1 2 3 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!